Biotechnology · Healthcare
Board Member
2021-09-15–present
Board Member
Syndax Pharmaceuticals Inc (SNDX)Equibles does not estimate personal net worth.
Get an email with a short summary when Syndax Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.
Get SNDX alertsMartin H. Huber is recorded as Board Member at Syndax Pharmaceuticals Inc (SNDX) since September 15, 2021. Syndax Pharmaceuticals Inc reported in an 8-K filed September 15, 2021 that Martin H. Huber was appointed Class II member of the Board, effective September 15, 2021. Syndax Pharmaceuticals Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Syndax Pharmaceuticals Inc includes Michael A. Metzger (CEO and Board Member), Michael Metzger (CEO), Aaron A. Ondrey (CFO and Chief Accounting Officer) and 6 others.
“The Board designated Dr. Huber as a Class II member to serve until the 2024 annual meeting of the Company’s stockholders, or until his successor has been duly elected and qualified, or until his earlier death, resignation or removal.”
2021-09-15–present
Biotechnology · Healthcare
Board Member
2021-09-15–present